105 related articles for article (PubMed ID: 7840506)
21. HER-2/neu (c-erb-B2) gene and protein in breast cancer.
Ross JS; Fletcher JA
Am J Clin Pathol; 1999 Jul; 112(1 Suppl 1):S53-67. PubMed ID: 10396301
[TBL] [Abstract][Full Text] [Related]
22. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
Gong Y; Booser DJ; Sneige N
Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical studies on c-erbB-2 oncoprotein expression in paraffin embedded tissues in invasive and non-invasive human breast lesions.
Pechoux C; Chardonnet Y; Noël P
Anticancer Res; 1994; 14(3B):1343-60. PubMed ID: 7915095
[TBL] [Abstract][Full Text] [Related]
24. Expression of topoisomerase IIalpha is associated with rapid cell proliferation, aneuploidy, and c-erbB2 overexpression in breast cancer.
Järvinen TA; Kononen J; Pelto-Huikko M; Isola J
Am J Pathol; 1996 Jun; 148(6):2073-82. PubMed ID: 8669491
[TBL] [Abstract][Full Text] [Related]
25. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.
Aryandono T; Harijadi ; Ghozali A
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217
[TBL] [Abstract][Full Text] [Related]
26. c-myc amplifications in primary breast carcinomas and their local recurrences.
Aulmann S; Adler N; Rom J; Helmchen B; Schirmacher P; Sinn HP
J Clin Pathol; 2006 Apr; 59(4):424-8. PubMed ID: 16497871
[TBL] [Abstract][Full Text] [Related]
27. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
Naidu R; Wahab NA; Yadav M; Kutty MK
Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
[TBL] [Abstract][Full Text] [Related]
28. Histological tumor grade correlates with HER2/c-erB-2 status in invasive breast cancer: a comparative analysis between immunohistochemical (CB11 clone and Herceptest), FISH and differential PCR procedures.
López-Guerrero JA; Navarro S; Noguera R; Almenar S; Pellin A; Vázquez C; Llombart-Bosch A
Arkh Patol; 2003; 65(1):50-5. PubMed ID: 12669615
[TBL] [Abstract][Full Text] [Related]
29. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.
Courjal F; Cuny M; Simony-Lafontaine J; Louason G; Speiser P; Zeillinger R; Rodriguez C; Theillet C
Cancer Res; 1997 Oct; 57(19):4360-7. PubMed ID: 9331099
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of plasma prolactin in breast cancer: comparison with the expression of c erb B-2 oncoprotein.
Bhatavdekar JM; Patel DD; Sherbet GV; Giri DD; Karelia NH; Vora HH; Shah NG; Suthar TP; Nadkarni SP; Balar DB
Eur J Surg Oncol; 1993 Oct; 19(5):409-13. PubMed ID: 8104829
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of c-erbB-2 oncoprotein in muscle-invasive bladder carcinoma: relationship with gene amplification, clinicopathological parameters and prognostic outcome.
Krüger S; Weitsch G; Büttner H; Matthiensen A; Böhmer T; Marquardt T; Sayk F; Feller AC; Böhle A
Int J Oncol; 2002 Nov; 21(5):981-7. PubMed ID: 12370744
[TBL] [Abstract][Full Text] [Related]
32. [Incidence of amplification of the C-erb B2/Her-2/neu gene in human breast cancer].
Sellami M; Gamoudi M; Krichen K; Kharrat A; Ben Romdhane K; Maalej M
Arch Inst Pasteur Tunis; 1991; 68(1-2):33-41. PubMed ID: 1687309
[TBL] [Abstract][Full Text] [Related]
33. Genetic analysis of HER-2/neu gene amplification in paraffin embedded tumour tissue in women with breast cancer.
Zadrozny M; Smolarz B; Romanowicz-Makowska H; Kozłowska E; Kulig A
Pol J Pathol; 2002; 53(4):189-93. PubMed ID: 12597335
[TBL] [Abstract][Full Text] [Related]
34. Proliferation measurement in breast cancer by two different methods.
Martínez-Arribas F; Martín-Garabato E; Lafuente P; Tejerina A; Lucas R; Sánchez J; Schneider J
Anticancer Res; 2006; 26(1A):199-202. PubMed ID: 16475699
[TBL] [Abstract][Full Text] [Related]
35. Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer.
Eskelinen M; Kataja V; Hämäläinen E; Kosma VM; Penttilä I; Alhava E
Anticancer Res; 1997; 17(2B):1231-4. PubMed ID: 9137478
[TBL] [Abstract][Full Text] [Related]
36. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the cellular centrosome in fine-needle aspirations of the breast.
Guo HQ; Gao M; Ma J; Xiao T; Zhao LL; Gao Y; Pan QJ
Breast Cancer Res; 2007; 9(4):R48. PubMed ID: 17662154
[TBL] [Abstract][Full Text] [Related]
38. [Prognosis value of p53, C-erB-2 and Ki67 proteins in ovarian carcinoma].
Frutuoso C; Silva MR; Amaral N; Martins I; De Oliveira C; De Oliveira HM
Acta Med Port; 2001; 14(3):277-83. PubMed ID: 11552325
[TBL] [Abstract][Full Text] [Related]
39. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
40. [Detection and significance of APC gene promoter hypermethylation in serum of breast cancer patients].
Zhang JJ; Ouyang T; Wan WH; Xu GW; Deng GR
Ai Zheng; 2007 Jan; 26(1):44-7. PubMed ID: 17222366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
